Gresham House Strategic plc specializes in PIPE, pre-IPO, growth and acquisition, recovery capital investments. The fund invests in financial services, media, information and communication technology, digital information and technology, healthcare, and life sciences. It prefers to invest in companies based in United Kingdom and Europe and can also co-invest outside Europe with local venture capital firms. The fund also seeks to make follow on investments. It invests in companies with market capitalizations of less than £250 million ($283.87 million) and seeks to acquire stakes between 5% and 25% for cash or share consideration. It seeks to invest between three to five years. The fund invests in smaller public companies as well as private companies. It invests in public companies that are listed on FTSE All-share and AIM All-Share Index; stocks trading greater than 50% below 3 year price high; EV or EBITDA less than 7 times, gearing more than 75%, ROCE greater than 10%, FCF Yield greater than 10%. The fund invests in private companies in P2P opportunities, equity and equity-related instruments, preferred equity, preferred quasi equity positions including convertible and non-convertible debt instruments, and mezzanine preferred instruments. It attracts portfolio in scenarios - excluding cash, portfolio trades on a weighted average EV or EBITDA greater than 5 times; generating in excess of 10% growth in 2017 based on broker forecasts. The fund targets 15% net IRR over the long-term.
Read More
